Axcella Health Inc. Common Stock
AXLA
AXLA was delisted on the 22nd of November, 2023.
38 hedge funds and large institutions have $97.3M invested in Axcella Health Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 18 reducing their positions, and 14 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
14% less funds holding
Funds holding: 44 → 38 (-6)
20% less capital invested
Capital invested by funds: $122M → $97.3M (-$24.3M)
43% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 14
67% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$353K |
| 2 |
Millennium Management
New York
|
+$313K |
| 3 |
E
Ergoteles
New York
|
+$254K |
| 4 |
HF
HRT Financial
New York
|
+$174K |
| 5 |
CCB
Cutter & Co Brokerage
Ballwin,
Missouri
|
+$140K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$2.95M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$615K |
| 3 |
State Street
Boston,
Massachusetts
|
-$608K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$553K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$372K |
AXLA Hedge Fund Activity: Q2 2021 in Review
38 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Axcella Health Inc. Common Stock (AXLA) for Q2 2021, worth a combined $97.3M — down 20% from $122M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of AXLA and 8 opened new positions — a net loss of 6 holders — while 18 trimmed existing stakes and 6 added.
The largest buyer was Renaissance Technologies, adding an estimated $353K. The largest seller was BlackRock, cutting an estimated $2.95M.
- 38 institutional investors held Axcella Health Inc. Common Stock (AXLA) as of Q2 2021, down from 44 in Q1 2021.
- Funds reported $97.3M of Axcella Health Inc. Common Stock stock for Q2 2021, down 20% quarter-over-quarter.
- 8 funds opened new Axcella Health Inc. Common Stock positions in Q2 2021 and 14 closed out, a net change of -6 holders.
- The largest Axcella Health Inc. Common Stock buyer in Q2 2021 was Renaissance Technologies, an estimated $353K added.
- The largest Axcella Health Inc. Common Stock seller in Q2 2021 was BlackRock, an estimated $2.95M sold.
Based on aggregated 13F filings for Q2 2021.